Details for New Drug Application (NDA): 090857
✉ Email this page to a colleague
The generic ingredient in CEFPROZIL is cefprozil. There are thirteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the cefprozil profile page.
Summary for 090857
Tradename: | CEFPROZIL |
Applicant: | Alkem Labs Ltd |
Ingredient: | cefprozil |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
Approval Date: | Apr 9, 2024 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
Approval Date: | Apr 9, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription